Company Profile
ProKidney Stock Price, News & Analysis
- Ticker:
- PROK
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
1.67 USD (+2.45%)
Close
Last updated: August 5, 2026
390M USD
Market cap
Why the stock is moving
As of Aug 5, 2026, PROK closed up 2.45% at $1.67. No new same-company headline was identified in the current news window.
Company overview
Business overview
ProKidney is a regenerative medicine company focused on cell therapy for chronic kidney disease.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, ProKidney sits in cell therapy and renal innovation.
Business Model Characteristics
The business is driven by clinical development, manufacturing execution, and the promise of disease-modifying kidney treatment.
Position Within the Biotechnology Landscape
ProKidney is a high-risk, high-catalyst kidney company where clinical data can quickly reshape the valuation.
Future catalysts
The next few months for ProKidney are centered on REGEN-007. The latest company update points to On track to complete enrollment for the Phase 3 PROACT 1 accelerated approval analysis of rilparencel in mid-2026. If that progress holds, the program should stay on the radar through the rest of the quarter.
Recent news
- 01
ProKidney Appoints Kenneth Locke as Chief Technical Officer
Source: ProKidney
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of ProKidney (PROK)?
ProKidney (PROK) most recently closed at 1.67 USD, a +2.45% move versus the previous session.
What is the market cap of ProKidney (PROK)?
ProKidney currently has a market capitalization of 390M USD on BioPharmSignal.
What does ProKidney do?
ProKidney is a regenerative medicine company focused on cell therapy for chronic kidney disease.
On which exchange is PROK stock listed?
ProKidney (PROK) is associated with NASDAQ, United States, Biopharma.
What is REGEN-007?
The next few months for ProKidney are centered on REGEN-007.
Which conditions is ProKidney targeting with REGEN-007?
The next few months for ProKidney are centered on REGEN-007.
How does ProKidney describe recent progress with REGEN-007?
The next few months for ProKidney are centered on REGEN-007.
What is ProKidney?
ProKidney is a regenerative medicine company focused on cell therapy for chronic kidney disease.